Episode 076: Management of primary refractory diffuse large B-cell lymphoma (DLBCL)

This week, we pick up on our discussion about management of DLBCL, focusing on the primary refractory setting. A big part of this discussion is the role of CAR-T therapy. If you have not done so already, we highly recommend you check out episode 075 for the fundamentals of CAR-T before proceeding with this episode!

Content:

- Definitions for "primary refractory" vs. "relapsed" disease

- How do we approach patients with primary refractory disease?

- What are the treatment regimens for patients with primary refractory disease?

- What is the role of CAR-T therapy?

- How do we "bridge" patients to CAR-T therapy?

- How do we monitor patients post CAR-T?

** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodes

Love what you hear? Tell a friend and leave a review on our podcast streaming platforms!

Twitter: @TheFellowOnCall

Instagram: @TheFellowOnCall

Listen in on: Apple Podcast, Spotify, and Google Podcast